Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -214
Accepted - Volume 3
Comment Record
Commentor
Dr. Charles Holt, D.o.
Date/Time
2002-11-08 18:23:37
Organization
VA
Category
Health Professional
Comments for FDA General
Questions
1. General Comments
We must allow testing of all ages of patients--a bio-agent release as a WMD could be the end of modern history as we know it.
EC -214